nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritonavir—ABCG2—Leflunomide—systemic scleroderma	0.0707	0.101	CbGbCtD
Ritonavir—CYP2C8—Mometasone—systemic scleroderma	0.0585	0.0838	CbGbCtD
Ritonavir—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.055	0.0788	CbGbCtD
Ritonavir—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0483	0.0693	CbGbCtD
Ritonavir—SLCO1A2—Prednisone—systemic scleroderma	0.0466	0.0668	CbGbCtD
Ritonavir—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0437	0.0626	CbGbCtD
Ritonavir—CYP1A2—Pentoxifylline—systemic scleroderma	0.0306	0.0438	CbGbCtD
Ritonavir—CYP1A2—Leflunomide—systemic scleroderma	0.0292	0.0418	CbGbCtD
Ritonavir—ABCB1—Lisinopril—systemic scleroderma	0.0267	0.0383	CbGbCtD
Ritonavir—CYP2C9—Leflunomide—systemic scleroderma	0.0263	0.0377	CbGbCtD
Ritonavir—ABCC1—Methotrexate—systemic scleroderma	0.0262	0.0375	CbGbCtD
Ritonavir—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0242	0.0347	CbGbCtD
Ritonavir—SLCO1A2—Methotrexate—systemic scleroderma	0.0234	0.0335	CbGbCtD
Ritonavir—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0233	0.0334	CbGbCtD
Ritonavir—SLCO1B1—Methotrexate—systemic scleroderma	0.0221	0.0316	CbGbCtD
Ritonavir—ABCB1—Captopril—systemic scleroderma	0.02	0.0287	CbGbCtD
Ritonavir—ABCC2—Methotrexate—systemic scleroderma	0.0194	0.0278	CbGbCtD
Ritonavir—CYP2D6—Captopril—systemic scleroderma	0.0189	0.027	CbGbCtD
Ritonavir—ABCG2—Methotrexate—systemic scleroderma	0.0175	0.0251	CbGbCtD
Ritonavir—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0158	0.0226	CbGbCtD
Ritonavir—CYP2C19—Prednisone—systemic scleroderma	0.0156	0.0224	CbGbCtD
Ritonavir—ABCB1—Prednisone—systemic scleroderma	0.0126	0.018	CbGbCtD
Ritonavir—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00944	0.0135	CbGbCtD
Ritonavir—CYP3A4—Prednisone—systemic scleroderma	0.00755	0.0108	CbGbCtD
Ritonavir—ABCB1—Methotrexate—systemic scleroderma	0.00632	0.00906	CbGbCtD
Ritonavir—CYP2C9—cardial valve—systemic scleroderma	0.00297	0.415	CbGeAlD
Ritonavir—SLC47A1—digestive system—systemic scleroderma	0.000258	0.0361	CbGeAlD
Ritonavir—SLCO1B1—digestive system—systemic scleroderma	0.000254	0.0356	CbGeAlD
Ritonavir—SLC47A1—tendon—systemic scleroderma	0.000245	0.0343	CbGeAlD
Ritonavir—SLC47A1—lung—systemic scleroderma	0.000215	0.0301	CbGeAlD
Ritonavir—SLCO1A2—digestive system—systemic scleroderma	0.000207	0.029	CbGeAlD
Ritonavir—ABCC2—digestive system—systemic scleroderma	0.000193	0.027	CbGeAlD
Ritonavir—ABCB1—blood vessel—systemic scleroderma	0.000187	0.0262	CbGeAlD
Ritonavir—ABCC2—tendon—systemic scleroderma	0.000184	0.0257	CbGeAlD
Ritonavir—SLCO1A2—lung—systemic scleroderma	0.000173	0.0242	CbGeAlD
Ritonavir—CYP2C19—digestive system—systemic scleroderma	0.000166	0.0232	CbGeAlD
Ritonavir—CYP2B6—skin of body—systemic scleroderma	0.000162	0.0227	CbGeAlD
Ritonavir—ABCC1—tendon—systemic scleroderma	0.000162	0.0226	CbGeAlD
Ritonavir—ABCC1—lung—systemic scleroderma	0.000142	0.0199	CbGeAlD
Ritonavir—CYP1A2—digestive system—systemic scleroderma	0.000135	0.0189	CbGeAlD
Ritonavir—CYP3A5—digestive system—systemic scleroderma	0.000131	0.0183	CbGeAlD
Ritonavir—CYP2B6—digestive system—systemic scleroderma	0.00013	0.0182	CbGeAlD
Ritonavir—CYP2C9—digestive system—systemic scleroderma	0.000129	0.018	CbGeAlD
Ritonavir—CYP2E1—digestive system—systemic scleroderma	0.000122	0.017	CbGeAlD
Ritonavir—ABCG2—lung—systemic scleroderma	0.000118	0.0164	CbGeAlD
Ritonavir—CYP2E1—tendon—systemic scleroderma	0.000116	0.0162	CbGeAlD
Ritonavir—CYP1A2—lung—systemic scleroderma	0.000113	0.0158	CbGeAlD
Ritonavir—CYP3A5—lung—systemic scleroderma	0.000109	0.0153	CbGeAlD
Ritonavir—Hypotension—Lisinopril—systemic scleroderma	0.000109	0.000369	CcSEcCtD
Ritonavir—Dizziness—Captopril—systemic scleroderma	0.000109	0.000369	CcSEcCtD
Ritonavir—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000109	0.000368	CcSEcCtD
Ritonavir—CYP2B6—lung—systemic scleroderma	0.000108	0.0152	CbGeAlD
Ritonavir—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000367	CcSEcCtD
Ritonavir—Depression—Prednisone—systemic scleroderma	0.000108	0.000366	CcSEcCtD
Ritonavir—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000366	CcSEcCtD
Ritonavir—Urticaria—Leflunomide—systemic scleroderma	0.000108	0.000365	CcSEcCtD
Ritonavir—Abdominal pain—Leflunomide—systemic scleroderma	0.000107	0.000363	CcSEcCtD
Ritonavir—Body temperature increased—Leflunomide—systemic scleroderma	0.000107	0.000363	CcSEcCtD
Ritonavir—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000107	0.000362	CcSEcCtD
Ritonavir—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000106	0.000361	CcSEcCtD
Ritonavir—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000361	CcSEcCtD
Ritonavir—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000361	CcSEcCtD
Ritonavir—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000361	CcSEcCtD
Ritonavir—Myocardial infarction—Prednisone—systemic scleroderma	0.000106	0.00036	CcSEcCtD
Ritonavir—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000106	0.00036	CcSEcCtD
Ritonavir—Breast disorder—Methotrexate—systemic scleroderma	0.000106	0.00036	CcSEcCtD
Ritonavir—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000106	0.00036	CcSEcCtD
Ritonavir—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000359	CcSEcCtD
Ritonavir—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000106	0.000359	CcSEcCtD
Ritonavir—Hypersensitivity—Azathioprine—systemic scleroderma	0.000106	0.000358	CcSEcCtD
Ritonavir—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000106	0.000358	CcSEcCtD
Ritonavir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000358	CcSEcCtD
Ritonavir—Insomnia—Lisinopril—systemic scleroderma	0.000105	0.000357	CcSEcCtD
Ritonavir—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000356	CcSEcCtD
Ritonavir—Paraesthesia—Lisinopril—systemic scleroderma	0.000105	0.000354	CcSEcCtD
Ritonavir—Vomiting—Captopril—systemic scleroderma	0.000104	0.000354	CcSEcCtD
Ritonavir—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000104	0.000353	CcSEcCtD
Ritonavir—Dyspnoea—Lisinopril—systemic scleroderma	0.000104	0.000352	CcSEcCtD
Ritonavir—Rash—Captopril—systemic scleroderma	0.000104	0.000351	CcSEcCtD
Ritonavir—Dermatitis—Captopril—systemic scleroderma	0.000104	0.000351	CcSEcCtD
Ritonavir—Somnolence—Lisinopril—systemic scleroderma	0.000103	0.000351	CcSEcCtD
Ritonavir—Headache—Captopril—systemic scleroderma	0.000103	0.000349	CcSEcCtD
Ritonavir—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000349	CcSEcCtD
Ritonavir—Dyspepsia—Lisinopril—systemic scleroderma	0.000102	0.000347	CcSEcCtD
Ritonavir—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000102	0.000346	CcSEcCtD
Ritonavir—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000102	0.000346	CcSEcCtD
Ritonavir—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000346	CcSEcCtD
Ritonavir—CYP2E1—lung—systemic scleroderma	0.000102	0.0142	CbGeAlD
Ritonavir—Asthma—Methotrexate—systemic scleroderma	0.000102	0.000345	CcSEcCtD
Ritonavir—Decreased appetite—Lisinopril—systemic scleroderma	0.000101	0.000343	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.0001	0.000341	CcSEcCtD
Ritonavir—Fatigue—Lisinopril—systemic scleroderma	0.0001	0.00034	CcSEcCtD
Ritonavir—Shock—Mycophenolate mofetil—systemic scleroderma	0.0001	0.00034	CcSEcCtD
Ritonavir—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.0001	0.000339	CcSEcCtD
Ritonavir—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	9.98e-05	0.000339	CcSEcCtD
Ritonavir—Hypersensitivity—Leflunomide—systemic scleroderma	9.98e-05	0.000338	CcSEcCtD
Ritonavir—Pancreatitis—Methotrexate—systemic scleroderma	9.96e-05	0.000338	CcSEcCtD
Ritonavir—Constipation—Lisinopril—systemic scleroderma	9.95e-05	0.000338	CcSEcCtD
Ritonavir—Pain—Lisinopril—systemic scleroderma	9.95e-05	0.000338	CcSEcCtD
Ritonavir—Tachycardia—Mycophenolate mofetil—systemic scleroderma	9.95e-05	0.000338	CcSEcCtD
Ritonavir—Skin disorder—Mycophenolate mofetil—systemic scleroderma	9.9e-05	0.000336	CcSEcCtD
Ritonavir—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	9.86e-05	0.000334	CcSEcCtD
Ritonavir—Diarrhoea—Azathioprine—systemic scleroderma	9.81e-05	0.000333	CcSEcCtD
Ritonavir—CYP3A4—digestive system—systemic scleroderma	9.8e-05	0.0137	CbGeAlD
Ritonavir—Haemoglobin—Prednisone—systemic scleroderma	9.78e-05	0.000332	CcSEcCtD
Ritonavir—Nausea—Captopril—systemic scleroderma	9.76e-05	0.000331	CcSEcCtD
Ritonavir—Haemorrhage—Prednisone—systemic scleroderma	9.73e-05	0.00033	CcSEcCtD
Ritonavir—Anorexia—Mycophenolate mofetil—systemic scleroderma	9.72e-05	0.00033	CcSEcCtD
Ritonavir—Asthenia—Leflunomide—systemic scleroderma	9.72e-05	0.00033	CcSEcCtD
Ritonavir—Hallucination—Prednisone—systemic scleroderma	9.68e-05	0.000328	CcSEcCtD
Ritonavir—CYP2D6—digestive system—systemic scleroderma	9.64e-05	0.0135	CbGeAlD
Ritonavir—Feeling abnormal—Lisinopril—systemic scleroderma	9.59e-05	0.000325	CcSEcCtD
Ritonavir—Pruritus—Leflunomide—systemic scleroderma	9.58e-05	0.000325	CcSEcCtD
Ritonavir—Connective tissue disorder—Prednisone—systemic scleroderma	9.56e-05	0.000324	CcSEcCtD
Ritonavir—Hypotension—Mycophenolate mofetil—systemic scleroderma	9.53e-05	0.000323	CcSEcCtD
Ritonavir—Gastrointestinal pain—Lisinopril—systemic scleroderma	9.52e-05	0.000323	CcSEcCtD
Ritonavir—Dysuria—Methotrexate—systemic scleroderma	9.5e-05	0.000322	CcSEcCtD
Ritonavir—Neutropenia—Methotrexate—systemic scleroderma	9.5e-05	0.000322	CcSEcCtD
Ritonavir—Dizziness—Azathioprine—systemic scleroderma	9.48e-05	0.000322	CcSEcCtD
Ritonavir—Erectile dysfunction—Methotrexate—systemic scleroderma	9.36e-05	0.000317	CcSEcCtD
Ritonavir—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	9.29e-05	0.000315	CcSEcCtD
Ritonavir—Photosensitivity reaction—Methotrexate—systemic scleroderma	9.27e-05	0.000314	CcSEcCtD
Ritonavir—Asthenia—Mycophenolic acid—systemic scleroderma	9.27e-05	0.000314	CcSEcCtD
Ritonavir—Diarrhoea—Leflunomide—systemic scleroderma	9.27e-05	0.000314	CcSEcCtD
Ritonavir—Urticaria—Lisinopril—systemic scleroderma	9.25e-05	0.000314	CcSEcCtD
Ritonavir—Insomnia—Mycophenolate mofetil—systemic scleroderma	9.22e-05	0.000313	CcSEcCtD
Ritonavir—Abdominal pain—Lisinopril—systemic scleroderma	9.2e-05	0.000312	CcSEcCtD
Ritonavir—Body temperature increased—Lisinopril—systemic scleroderma	9.2e-05	0.000312	CcSEcCtD
Ritonavir—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	9.16e-05	0.000311	CcSEcCtD
Ritonavir—Pruritus—Mycophenolic acid—systemic scleroderma	9.14e-05	0.00031	CcSEcCtD
Ritonavir—Vomiting—Azathioprine—systemic scleroderma	9.12e-05	0.000309	CcSEcCtD
Ritonavir—Eye disorder—Prednisone—systemic scleroderma	9.09e-05	0.000308	CcSEcCtD
Ritonavir—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	9.09e-05	0.000308	CcSEcCtD
Ritonavir—Somnolence—Mycophenolate mofetil—systemic scleroderma	9.07e-05	0.000307	CcSEcCtD
Ritonavir—Rash—Azathioprine—systemic scleroderma	9.04e-05	0.000307	CcSEcCtD
Ritonavir—Dermatitis—Azathioprine—systemic scleroderma	9.03e-05	0.000306	CcSEcCtD
Ritonavir—Depression—Methotrexate—systemic scleroderma	9.03e-05	0.000306	CcSEcCtD
Ritonavir—Flushing—Prednisone—systemic scleroderma	9.03e-05	0.000306	CcSEcCtD
Ritonavir—Headache—Azathioprine—systemic scleroderma	8.98e-05	0.000305	CcSEcCtD
Ritonavir—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	8.98e-05	0.000304	CcSEcCtD
Ritonavir—Dizziness—Leflunomide—systemic scleroderma	8.96e-05	0.000304	CcSEcCtD
Ritonavir—Renal failure—Methotrexate—systemic scleroderma	8.9e-05	0.000302	CcSEcCtD
Ritonavir—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	8.86e-05	0.000301	CcSEcCtD
Ritonavir—Diarrhoea—Mycophenolic acid—systemic scleroderma	8.84e-05	0.0003	CcSEcCtD
Ritonavir—Stomatitis—Methotrexate—systemic scleroderma	8.83e-05	0.000299	CcSEcCtD
Ritonavir—Angiopathy—Prednisone—systemic scleroderma	8.83e-05	0.000299	CcSEcCtD
Ritonavir—Conjunctivitis—Methotrexate—systemic scleroderma	8.8e-05	0.000299	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	8.8e-05	0.000299	CcSEcCtD
Ritonavir—Immune system disorder—Prednisone—systemic scleroderma	8.79e-05	0.000298	CcSEcCtD
Ritonavir—Pain—Mycophenolate mofetil—systemic scleroderma	8.72e-05	0.000296	CcSEcCtD
Ritonavir—Constipation—Mycophenolate mofetil—systemic scleroderma	8.72e-05	0.000296	CcSEcCtD
Ritonavir—Sweating—Methotrexate—systemic scleroderma	8.68e-05	0.000294	CcSEcCtD
Ritonavir—Haematuria—Methotrexate—systemic scleroderma	8.64e-05	0.000293	CcSEcCtD
Ritonavir—Vomiting—Leflunomide—systemic scleroderma	8.61e-05	0.000292	CcSEcCtD
Ritonavir—Hypersensitivity—Lisinopril—systemic scleroderma	8.57e-05	0.000291	CcSEcCtD
Ritonavir—Hepatobiliary disease—Methotrexate—systemic scleroderma	8.57e-05	0.000291	CcSEcCtD
Ritonavir—Dizziness—Mycophenolic acid—systemic scleroderma	8.54e-05	0.00029	CcSEcCtD
Ritonavir—Epistaxis—Methotrexate—systemic scleroderma	8.54e-05	0.00029	CcSEcCtD
Ritonavir—Rash—Leflunomide—systemic scleroderma	8.54e-05	0.00029	CcSEcCtD
Ritonavir—Dermatitis—Leflunomide—systemic scleroderma	8.53e-05	0.000289	CcSEcCtD
Ritonavir—Mental disorder—Prednisone—systemic scleroderma	8.52e-05	0.000289	CcSEcCtD
Ritonavir—Nausea—Azathioprine—systemic scleroderma	8.52e-05	0.000289	CcSEcCtD
Ritonavir—Headache—Leflunomide—systemic scleroderma	8.49e-05	0.000288	CcSEcCtD
Ritonavir—Malnutrition—Prednisone—systemic scleroderma	8.47e-05	0.000287	CcSEcCtD
Ritonavir—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	8.4e-05	0.000285	CcSEcCtD
Ritonavir—Asthenia—Lisinopril—systemic scleroderma	8.35e-05	0.000283	CcSEcCtD
Ritonavir—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	8.34e-05	0.000283	CcSEcCtD
Ritonavir—Pruritus—Lisinopril—systemic scleroderma	8.23e-05	0.000279	CcSEcCtD
Ritonavir—Vomiting—Mycophenolic acid—systemic scleroderma	8.22e-05	0.000279	CcSEcCtD
Ritonavir—Haemoglobin—Methotrexate—systemic scleroderma	8.17e-05	0.000277	CcSEcCtD
Ritonavir—Rash—Mycophenolic acid—systemic scleroderma	8.15e-05	0.000276	CcSEcCtD
Ritonavir—Dermatitis—Mycophenolic acid—systemic scleroderma	8.14e-05	0.000276	CcSEcCtD
Ritonavir—Haemorrhage—Methotrexate—systemic scleroderma	8.13e-05	0.000276	CcSEcCtD
Ritonavir—Hepatitis—Methotrexate—systemic scleroderma	8.13e-05	0.000276	CcSEcCtD
Ritonavir—Urticaria—Mycophenolate mofetil—systemic scleroderma	8.1e-05	0.000275	CcSEcCtD
Ritonavir—Headache—Mycophenolic acid—systemic scleroderma	8.09e-05	0.000275	CcSEcCtD
Ritonavir—Pharyngitis—Methotrexate—systemic scleroderma	8.07e-05	0.000274	CcSEcCtD
Ritonavir—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	8.06e-05	0.000273	CcSEcCtD
Ritonavir—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	8.06e-05	0.000273	CcSEcCtD
Ritonavir—Nausea—Leflunomide—systemic scleroderma	8.05e-05	0.000273	CcSEcCtD
Ritonavir—Urinary tract disorder—Methotrexate—systemic scleroderma	8.03e-05	0.000272	CcSEcCtD
Ritonavir—Vision blurred—Prednisone—systemic scleroderma	7.98e-05	0.000271	CcSEcCtD
Ritonavir—Urethral disorder—Methotrexate—systemic scleroderma	7.97e-05	0.00027	CcSEcCtD
Ritonavir—Diarrhoea—Lisinopril—systemic scleroderma	7.96e-05	0.00027	CcSEcCtD
Ritonavir—Ill-defined disorder—Prednisone—systemic scleroderma	7.86e-05	0.000266	CcSEcCtD
Ritonavir—Visual impairment—Methotrexate—systemic scleroderma	7.84e-05	0.000266	CcSEcCtD
Ritonavir—Anaemia—Prednisone—systemic scleroderma	7.83e-05	0.000265	CcSEcCtD
Ritonavir—Agitation—Prednisone—systemic scleroderma	7.78e-05	0.000264	CcSEcCtD
Ritonavir—Dizziness—Lisinopril—systemic scleroderma	7.7e-05	0.000261	CcSEcCtD
Ritonavir—Erythema multiforme—Methotrexate—systemic scleroderma	7.69e-05	0.000261	CcSEcCtD
Ritonavir—Nausea—Mycophenolic acid—systemic scleroderma	7.67e-05	0.00026	CcSEcCtD
Ritonavir—Malaise—Prednisone—systemic scleroderma	7.64e-05	0.000259	CcSEcCtD
Ritonavir—Vertigo—Prednisone—systemic scleroderma	7.61e-05	0.000258	CcSEcCtD
Ritonavir—Eye disorder—Methotrexate—systemic scleroderma	7.6e-05	0.000258	CcSEcCtD
Ritonavir—Syncope—Prednisone—systemic scleroderma	7.6e-05	0.000258	CcSEcCtD
Ritonavir—Tinnitus—Methotrexate—systemic scleroderma	7.58e-05	0.000257	CcSEcCtD
Ritonavir—Cardiac disorder—Methotrexate—systemic scleroderma	7.55e-05	0.000256	CcSEcCtD
Ritonavir—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	7.51e-05	0.000255	CcSEcCtD
Ritonavir—Loss of consciousness—Prednisone—systemic scleroderma	7.44e-05	0.000252	CcSEcCtD
Ritonavir—Vomiting—Lisinopril—systemic scleroderma	7.4e-05	0.000251	CcSEcCtD
Ritonavir—Angiopathy—Methotrexate—systemic scleroderma	7.38e-05	0.00025	CcSEcCtD
Ritonavir—Immune system disorder—Methotrexate—systemic scleroderma	7.34e-05	0.000249	CcSEcCtD
Ritonavir—Rash—Lisinopril—systemic scleroderma	7.34e-05	0.000249	CcSEcCtD
Ritonavir—Convulsion—Prednisone—systemic scleroderma	7.34e-05	0.000249	CcSEcCtD
Ritonavir—Dermatitis—Lisinopril—systemic scleroderma	7.33e-05	0.000249	CcSEcCtD
Ritonavir—Mediastinal disorder—Methotrexate—systemic scleroderma	7.33e-05	0.000249	CcSEcCtD
Ritonavir—Asthenia—Mycophenolate mofetil—systemic scleroderma	7.32e-05	0.000248	CcSEcCtD
Ritonavir—Hypertension—Prednisone—systemic scleroderma	7.31e-05	0.000248	CcSEcCtD
Ritonavir—Chills—Methotrexate—systemic scleroderma	7.3e-05	0.000247	CcSEcCtD
Ritonavir—Headache—Lisinopril—systemic scleroderma	7.29e-05	0.000247	CcSEcCtD
Ritonavir—Pruritus—Mycophenolate mofetil—systemic scleroderma	7.21e-05	0.000245	CcSEcCtD
Ritonavir—Arthralgia—Prednisone—systemic scleroderma	7.21e-05	0.000245	CcSEcCtD
Ritonavir—Myalgia—Prednisone—systemic scleroderma	7.21e-05	0.000245	CcSEcCtD
Ritonavir—Anxiety—Prednisone—systemic scleroderma	7.19e-05	0.000244	CcSEcCtD
Ritonavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	7.16e-05	0.000243	CcSEcCtD
Ritonavir—Discomfort—Prednisone—systemic scleroderma	7.12e-05	0.000242	CcSEcCtD
Ritonavir—Mental disorder—Methotrexate—systemic scleroderma	7.12e-05	0.000242	CcSEcCtD
Ritonavir—Malnutrition—Methotrexate—systemic scleroderma	7.08e-05	0.00024	CcSEcCtD
Ritonavir—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	6.98e-05	0.000237	CcSEcCtD
Ritonavir—ABCB1—digestive system—systemic scleroderma	6.94e-05	0.0097	CbGeAlD
Ritonavir—Dysgeusia—Methotrexate—systemic scleroderma	6.93e-05	0.000235	CcSEcCtD
Ritonavir—Nausea—Lisinopril—systemic scleroderma	6.91e-05	0.000234	CcSEcCtD
Ritonavir—Oedema—Prednisone—systemic scleroderma	6.91e-05	0.000234	CcSEcCtD
Ritonavir—Back pain—Methotrexate—systemic scleroderma	6.85e-05	0.000232	CcSEcCtD
Ritonavir—Shock—Prednisone—systemic scleroderma	6.8e-05	0.000231	CcSEcCtD
Ritonavir—Nervous system disorder—Prednisone—systemic scleroderma	6.78e-05	0.00023	CcSEcCtD
Ritonavir—Tachycardia—Prednisone—systemic scleroderma	6.75e-05	0.000229	CcSEcCtD
Ritonavir—Dizziness—Mycophenolate mofetil—systemic scleroderma	6.74e-05	0.000229	CcSEcCtD
Ritonavir—Skin disorder—Prednisone—systemic scleroderma	6.71e-05	0.000228	CcSEcCtD
Ritonavir—Hyperhidrosis—Prednisone—systemic scleroderma	6.68e-05	0.000227	CcSEcCtD
Ritonavir—Vision blurred—Methotrexate—systemic scleroderma	6.67e-05	0.000226	CcSEcCtD
Ritonavir—Anorexia—Prednisone—systemic scleroderma	6.59e-05	0.000223	CcSEcCtD
Ritonavir—Ill-defined disorder—Methotrexate—systemic scleroderma	6.57e-05	0.000223	CcSEcCtD
Ritonavir—Anaemia—Methotrexate—systemic scleroderma	6.54e-05	0.000222	CcSEcCtD
Ritonavir—Vomiting—Mycophenolate mofetil—systemic scleroderma	6.48e-05	0.00022	CcSEcCtD
Ritonavir—Rash—Mycophenolate mofetil—systemic scleroderma	6.43e-05	0.000218	CcSEcCtD
Ritonavir—Dermatitis—Mycophenolate mofetil—systemic scleroderma	6.42e-05	0.000218	CcSEcCtD
Ritonavir—Headache—Mycophenolate mofetil—systemic scleroderma	6.39e-05	0.000217	CcSEcCtD
Ritonavir—Malaise—Methotrexate—systemic scleroderma	6.38e-05	0.000216	CcSEcCtD
Ritonavir—Vertigo—Methotrexate—systemic scleroderma	6.36e-05	0.000216	CcSEcCtD
Ritonavir—Leukopenia—Methotrexate—systemic scleroderma	6.34e-05	0.000215	CcSEcCtD
Ritonavir—Musculoskeletal discomfort—Prednisone—systemic scleroderma	6.3e-05	0.000214	CcSEcCtD
Ritonavir—Insomnia—Prednisone—systemic scleroderma	6.25e-05	0.000212	CcSEcCtD
Ritonavir—Paraesthesia—Prednisone—systemic scleroderma	6.21e-05	0.00021	CcSEcCtD
Ritonavir—Cough—Methotrexate—systemic scleroderma	6.18e-05	0.000209	CcSEcCtD
Ritonavir—Convulsion—Methotrexate—systemic scleroderma	6.13e-05	0.000208	CcSEcCtD
Ritonavir—Dyspepsia—Prednisone—systemic scleroderma	6.08e-05	0.000206	CcSEcCtD
Ritonavir—Nausea—Mycophenolate mofetil—systemic scleroderma	6.06e-05	0.000205	CcSEcCtD
Ritonavir—Chest pain—Methotrexate—systemic scleroderma	6.03e-05	0.000204	CcSEcCtD
Ritonavir—Arthralgia—Methotrexate—systemic scleroderma	6.03e-05	0.000204	CcSEcCtD
Ritonavir—Myalgia—Methotrexate—systemic scleroderma	6.03e-05	0.000204	CcSEcCtD
Ritonavir—Decreased appetite—Prednisone—systemic scleroderma	6.01e-05	0.000204	CcSEcCtD
Ritonavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	5.98e-05	0.000203	CcSEcCtD
Ritonavir—Fatigue—Prednisone—systemic scleroderma	5.96e-05	0.000202	CcSEcCtD
Ritonavir—Discomfort—Methotrexate—systemic scleroderma	5.95e-05	0.000202	CcSEcCtD
Ritonavir—Constipation—Prednisone—systemic scleroderma	5.91e-05	0.0002	CcSEcCtD
Ritonavir—Confusional state—Methotrexate—systemic scleroderma	5.82e-05	0.000198	CcSEcCtD
Ritonavir—ABCB1—lung—systemic scleroderma	5.79e-05	0.0081	CbGeAlD
Ritonavir—Feeling abnormal—Prednisone—systemic scleroderma	5.7e-05	0.000193	CcSEcCtD
Ritonavir—Nervous system disorder—Methotrexate—systemic scleroderma	5.67e-05	0.000192	CcSEcCtD
Ritonavir—Thrombocytopenia—Methotrexate—systemic scleroderma	5.66e-05	0.000192	CcSEcCtD
Ritonavir—Gastrointestinal pain—Prednisone—systemic scleroderma	5.65e-05	0.000192	CcSEcCtD
Ritonavir—Skin disorder—Methotrexate—systemic scleroderma	5.61e-05	0.00019	CcSEcCtD
Ritonavir—Hyperhidrosis—Methotrexate—systemic scleroderma	5.58e-05	0.000189	CcSEcCtD
Ritonavir—Anorexia—Methotrexate—systemic scleroderma	5.51e-05	0.000187	CcSEcCtD
Ritonavir—Urticaria—Prednisone—systemic scleroderma	5.49e-05	0.000186	CcSEcCtD
Ritonavir—Abdominal pain—Prednisone—systemic scleroderma	5.46e-05	0.000185	CcSEcCtD
Ritonavir—Body temperature increased—Prednisone—systemic scleroderma	5.46e-05	0.000185	CcSEcCtD
Ritonavir—Hypotension—Methotrexate—systemic scleroderma	5.4e-05	0.000183	CcSEcCtD
Ritonavir—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	5.26e-05	0.000178	CcSEcCtD
Ritonavir—Insomnia—Methotrexate—systemic scleroderma	5.22e-05	0.000177	CcSEcCtD
Ritonavir—Paraesthesia—Methotrexate—systemic scleroderma	5.19e-05	0.000176	CcSEcCtD
Ritonavir—Dyspnoea—Methotrexate—systemic scleroderma	5.15e-05	0.000175	CcSEcCtD
Ritonavir—Somnolence—Methotrexate—systemic scleroderma	5.14e-05	0.000174	CcSEcCtD
Ritonavir—Hypersensitivity—Prednisone—systemic scleroderma	5.09e-05	0.000173	CcSEcCtD
Ritonavir—Dyspepsia—Methotrexate—systemic scleroderma	5.08e-05	0.000172	CcSEcCtD
Ritonavir—Decreased appetite—Methotrexate—systemic scleroderma	5.02e-05	0.00017	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Methotrexate—systemic scleroderma	4.99e-05	0.000169	CcSEcCtD
Ritonavir—Fatigue—Methotrexate—systemic scleroderma	4.98e-05	0.000169	CcSEcCtD
Ritonavir—Asthenia—Prednisone—systemic scleroderma	4.96e-05	0.000168	CcSEcCtD
Ritonavir—Pain—Methotrexate—systemic scleroderma	4.94e-05	0.000168	CcSEcCtD
Ritonavir—Pruritus—Prednisone—systemic scleroderma	4.89e-05	0.000166	CcSEcCtD
Ritonavir—Feeling abnormal—Methotrexate—systemic scleroderma	4.76e-05	0.000161	CcSEcCtD
Ritonavir—Diarrhoea—Prednisone—systemic scleroderma	4.73e-05	0.00016	CcSEcCtD
Ritonavir—Gastrointestinal pain—Methotrexate—systemic scleroderma	4.72e-05	0.00016	CcSEcCtD
Ritonavir—Urticaria—Methotrexate—systemic scleroderma	4.59e-05	0.000156	CcSEcCtD
Ritonavir—Dizziness—Prednisone—systemic scleroderma	4.57e-05	0.000155	CcSEcCtD
Ritonavir—Abdominal pain—Methotrexate—systemic scleroderma	4.57e-05	0.000155	CcSEcCtD
Ritonavir—Body temperature increased—Methotrexate—systemic scleroderma	4.57e-05	0.000155	CcSEcCtD
Ritonavir—Vomiting—Prednisone—systemic scleroderma	4.39e-05	0.000149	CcSEcCtD
Ritonavir—Rash—Prednisone—systemic scleroderma	4.36e-05	0.000148	CcSEcCtD
Ritonavir—Dermatitis—Prednisone—systemic scleroderma	4.35e-05	0.000148	CcSEcCtD
Ritonavir—Headache—Prednisone—systemic scleroderma	4.33e-05	0.000147	CcSEcCtD
Ritonavir—Hypersensitivity—Methotrexate—systemic scleroderma	4.26e-05	0.000144	CcSEcCtD
Ritonavir—Asthenia—Methotrexate—systemic scleroderma	4.14e-05	0.000141	CcSEcCtD
Ritonavir—Nausea—Prednisone—systemic scleroderma	4.11e-05	0.000139	CcSEcCtD
Ritonavir—Pruritus—Methotrexate—systemic scleroderma	4.09e-05	0.000139	CcSEcCtD
Ritonavir—Diarrhoea—Methotrexate—systemic scleroderma	3.95e-05	0.000134	CcSEcCtD
Ritonavir—Dizziness—Methotrexate—systemic scleroderma	3.82e-05	0.00013	CcSEcCtD
Ritonavir—Vomiting—Methotrexate—systemic scleroderma	3.67e-05	0.000125	CcSEcCtD
Ritonavir—Rash—Methotrexate—systemic scleroderma	3.64e-05	0.000124	CcSEcCtD
Ritonavir—Dermatitis—Methotrexate—systemic scleroderma	3.64e-05	0.000123	CcSEcCtD
Ritonavir—Headache—Methotrexate—systemic scleroderma	3.62e-05	0.000123	CcSEcCtD
Ritonavir—Nausea—Methotrexate—systemic scleroderma	3.43e-05	0.000116	CcSEcCtD
